FDA secrets: Why drug failures stay hidden.

A close look at the opaque side of pharmaceutical regulation reveals a critical gap. While FDA approvals are broadcast, the fate of unsuccessful drug applications often remains confidential, relying solely on the sponsoring company for disclosure. This unique perspective unpacks the reality versus the promise of timely public notification regarding Complete Response Letters, leaving observers checking for news that never comes. It raises serious questions about transparency in drug development oversight.
#pharmaceuticals #drugapproval #FDA #drugdevelopment #regulatoryaffairs #healthpolicy

Видео FDA secrets: Why drug failures stay hidden. канала Dan Sfera